Artal Group S.A. - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 156 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2021$977,000
-71.2%
100,0000.0%0.03%
-64.5%
Q3 2021$3,398,000
-53.6%
100,000
-50.0%
0.08%
-49.0%
Q2 2021$7,322,000
-18.4%
200,0000.0%0.15%
-5.7%
Q1 2021$8,968,000
-68.6%
200,000
-60.0%
0.16%
-74.2%
Q4 2020$28,535,000
-7.3%
500,000
-16.7%
0.61%
-17.9%
Q3 2020$30,780,000
-20.7%
600,000
-7.7%
0.75%
-31.2%
Q2 2020$38,818,000
+17.9%
650,000
-18.8%
1.09%
-22.0%
Q1 2020$32,936,000
+111.7%
800,000
+220.0%
1.39%
+131.6%
Q4 2019$15,560,000
-8.3%
250,000
-50.0%
0.60%
-11.6%
Q3 2019$16,970,000500,0000.68%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q4 2019
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$18,687,87215.44%
Redmile Group, LLC 5,582,105$86,243,5223.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,218,638$80,627,9571.80%
BRAIDWELL LP 3,241,351$50,078,8731.65%
Parkman Healthcare Partners LLC 491,772$7,597,8771.65%
Sunesis Advisors, LLC 96,299$1,487,8201.07%
ARMISTICE CAPITAL, LLC 4,100,000$63,345,0000.91%
Deep Track Capital, LP 1,363,201$21,061,4550.86%
AlphaCentric Advisors LLC 72,500$1,120,1250.77%
Ikarian Capital, LLC 174,510$2,696,1790.61%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders